Novolog (Pharm-Up 1966) Statistics

Total Valuation

Novolog (Pharm-Up 1966) has a market cap or net worth of ILS 865.67 million. The enterprise value is 853.08 million.

Market Cap	865.67M
Enterprise Value	853.08M

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	Sep 3, 2024

Share Statistics

Novolog (Pharm-Up 1966) has 510.72 million shares outstanding. The number of shares has decreased by -0.61% in one year.

Current Share Class	n/a
Shares Outstanding	510.72M
Shares Change (YoY)	-0.61%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.61%
Owned by Institutions (%)	59.96%
Float	330.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.51
PB Ratio	2.28
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.83, with an EV/FCF ratio of -69.46.

EV / Earnings	-48.64
EV / Sales	0.51
EV / EBITDA	5.83
EV / EBIT	17.03
EV / FCF	-69.46

Financial Position

The company has a current ratio of 0.96, with a Debt / Equity ratio of 0.52.

Current Ratio	0.96
Quick Ratio	0.86
Debt / Equity	0.52
Debt / EBITDA	1.37
Debt / FCF	-16.84
Interest Coverage	3.32

Financial Efficiency

Return on equity (ROE) is -3.65% and return on invested capital (ROIC) is 5.43%.

Return on Equity (ROE)	-3.65%
Return on Assets (ROA)	1.20%
Return on Capital (ROIC)	5.43%
Revenue Per Employee	1.76M
Profits Per Employee	-18,366
Employee Count	955
Asset Turnover	0.59
Inventory Turnover	6.53

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.33% in the last 52 weeks. The beta is 0.37, so Novolog (Pharm-Up 1966)'s price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	+1.33%
50-Day Moving Average	150.68
200-Day Moving Average	149.26
Relative Strength Index (RSI)	72.43
Average Volume (20 Days)	644,926

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novolog (Pharm-Up 1966) had revenue of ILS 1.68 billion and -17.54 million in losses. Loss per share was -0.04.

Revenue	1.68B
Gross Profit	173.56M
Operating Income	54.75M
Pretax Income	-3.51M
Net Income	-17.54M
EBITDA	126.31M
EBIT	54.75M
Loss Per Share	-0.04

Full Income Statement

Balance Sheet

The company has 234.51 million in cash and 206.82 million in debt, giving a net cash position of 27.69 million or 0.05 per share.

Cash & Cash Equivalents	234.51M
Total Debt	206.82M
Net Cash	27.69M
Net Cash Per Share	0.05
Equity (Book Value)	394.73M
Book Value Per Share	0.74
Working Capital	-83.65M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 48.58 million and capital expenditures -60.86 million, giving a free cash flow of -12.28 million.

Operating Cash Flow	48.58M
Capital Expenditures	-60.86M
Free Cash Flow	-12.28M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross margin is 10.31%, with operating and profit margins of 3.25% and -1.04%.

Gross Margin	10.31%
Operating Margin	3.25%
Pretax Margin	-0.21%
Profit Margin	-1.04%
EBITDA Margin	7.50%
EBIT Margin	3.25%
FCF Margin	-0.73%

Dividends & Yields

This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 3.61%.

Dividend Per Share	0.06
Dividend Yield	3.61%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.61%
Shareholder Yield	4.22%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novolog (Pharm-Up 1966) has an Altman Z-Score of 0.84. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.84
Piotroski F-Score	n/a